Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/46331
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | McGregor, C. | - |
dc.contributor.author | Srisurapanont, M. | - |
dc.contributor.author | Mitchell, A. | - |
dc.contributor.author | Longo, M. | - |
dc.contributor.author | Cahill, S. | - |
dc.contributor.author | White, J. | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Journal of Substance Abuse Treatment, 2008; 34(4):443-449 | - |
dc.identifier.issn | 0740-5472 | - |
dc.identifier.issn | 1873-6483 | - |
dc.identifier.uri | http://hdl.handle.net/2440/46331 | - |
dc.description | Copyright © 2008 Elsevier Inc. All rights reserved. | - |
dc.description.abstract | Testing of a new scale, the Amphetamine Cessation Symptom Assessment (ACSA), in a sample of treatment-seeking amphetamine users (N = 133) showed satisfactory reliability, while factor analysis identified three components explaining 64.7% of the variance in scores. Scores were inversely related to subjective general well-being (r = -.33, p < .01) and directly related to the Beck Depression Inventory (r = .59, p < .01). There were positive relationships between the ACSA and measures of amphetamine dependence (r = .36, p < .01) and the intensity of recent amphetamine use (r = .24, p < .01). The ACSA discriminated between "low-dose" and "high-dose" users, indicating discriminant validity. In inpatients (n = 63), ACSA scores declined significantly over time, while higher scores in inpatient treatment dropouts indicated predictive validity. The ACSA showed satisfactory reliability and validity, with a three-factor solution providing the best fit to the data. The ACSA could play an important role in providing clinical outcome data, particularly in outcome evaluation of new treatment protocols. | - |
dc.description.statementofresponsibility | Catherine McGregor, Manit Srisurapanont, Amanda Mitchell, Marie C. Longo, Sharon Cahill and Jason M. White | - |
dc.description.uri | http://www.elsevier.com/wps/find/journaldescription.cws_home/525475/description#description | - |
dc.language.iso | en | - |
dc.publisher | Pergamon-Elsevier Science Ltd | - |
dc.source.uri | http://dx.doi.org/10.1016/j.jsat.2007.05.007 | - |
dc.subject | Humans | - |
dc.subject | Substance-Related Disorders | - |
dc.subject | Amphetamine | - |
dc.subject | Factor Analysis, Statistical | - |
dc.subject | Reproducibility of Results | - |
dc.subject | Psychometrics | - |
dc.subject | Diagnostic and Statistical Manual of Mental Disorders | - |
dc.subject | Adult | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.subject | Surveys and Questionnaires | - |
dc.title | Psychometric evaluation of the Amphetamine Cessation Symptom Assessment | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.jsat.2007.05.007 | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest 6 Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.